Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Director's Dealing 2022

Sep 1, 2022

65058_rns_2022-09-01_e19b6127-78b0-447d-b18a-e5e78f0d8640.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HEALIUS LIMITED
ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Gordon Richard Davis
Date of last notice 24 February2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 319] intentionally omitted <==

----- Start of picture text ----- Direct or indirect interest DirectNature of indirect interest(including registered holder) N/ANote: Provide details of the circumstances givingrise to the relevant interest.Date of change 02 September 20228,032 NED Share Rights Gordon Davis8,032 Ordinary Shares* Gordon DavisNo. of securities held prior tochangeGR & G Davis55,759 Ordinary SharesSuperannuation Fund* Shares are subject to a holding lock as “Restricted Securities”under the NED Share Plan.Class Fully paid Ordinary SharesNumber acquired 8,032Number disposed N/A----- End of picture text -----

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation $40,000 cash equivalent using the volume weightedaverage price of Ordinary Shares over the five businessdays immediately following the Healius Limited AnnualGeneral Meeting on 21 October 2021, being $4.98.
No. of securities held afterchange 16,064 Ordinary Shares*Gordon Davis55,759 Ordinary SharesGR & G DavisSuperannuation Fund*Shares are subject to a holding lock as “RestrictedSecurities” under the NED Share Plan.
Nature of changeExample: on-market trade, off-market trade,exercise of options, issue of securities under Vesting of remaining 50% of NED Share Rights issuedin respect of FY 2022 into Ordinary Shares (restricted)
dividend reinvestment plan, participation in buy- under the NED Share Plan.
back

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed period whereprior written clearance was required? Not applicable
If so, was prior written clearance provided to allow thetrade to proceed during this period? Not applicable
If prior written clearance was provided, on what datewas this provided? Not applicable

Authorised by the Company Secretary.

Charles Tilley Company Secretary Date: 02 September 2022

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011